Unimark Remedies, Ltd.   Report issue

For profit Phase 3
Founded: Mumbai India (1982)
Status: No NME R&D (1982)

Organization Overview

First Clinical Trial
2008
NCT01767922
First Marketed Drug
2014
montelukast (singulair)
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

ISOCLIN | UNIMARK REMEDIES LTD